Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Biglari Holdings Class B
BH
$1.23B
| $296K | ﹤0.01% |
2,046
-1,230
| -38% | -$165K |
|
3477
Global X Silver Miners ETF NEW
SIL
$4.87B
| $295K | ﹤0.01% |
8,100
-2,031
| -20% | -$72K |
|
3478
Aveanna Healthcare
AVAH
$2.52B
| $293K | ﹤0.01% |
+85,784
| New | +$466K |
|
3479
CNA Financial
CNA
$13.8B
| $292K | ﹤0.01% |
+6,000
| New | +$279K |
|
3480
IT Tech Packaging
ITP
$2.88M
| $292K | ﹤0.01% |
131,367
+41,541
| +46% | +$87.5K |
|
|
HSTO
3481
DELISTED
Histogen Inc. Common Stock
HSTO
| $292K | ﹤0.01% |
58,353
+25,719
| +79% | +$130K |
|
3482
Weave Communications
WEAV
$424M
| $291K | ﹤0.01% |
+48,900
| New | +$435K |
|
3483
Rambus
RMBS
$10.7B
| $290K | ﹤0.01% |
9,100
-287,386
| -97% | -$7.95M |
|
3484
Keros Therapeutics
KROS
$207M
| $288K | ﹤0.01% |
+5,300
| New | +$272K |
|
3485
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
| $288K | ﹤0.01% |
7,200
-9,900
| -58% | -$395K |
|
3486
Abits Group
ABTS
$4.03M
| $287K | ﹤0.01% |
11,966
+1,853
| +18% | +$54.6K |
|
3487
Amneal Pharmaceuticals
AMRX
$6.03B
| $286K | ﹤0.01% |
+68,600
| New | +$304K |
|
|
ELP
3488
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $286K | ﹤0.01% |
+45,750
| New | +$239K |
|
3489
Flotek Industries
FTK
$1.26B
| $286K | ﹤0.01% |
+37,791
| New | +$270K |
|
3490
Plumas Bancorp
PLBC
$438M
| $286K | ﹤0.01% |
7,500
-4,500
| -38% | -$169K |
|
|
VBIV
3491
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $286K | ﹤0.01% |
+5,737
| New | +$283K |
|
|
ALBO
3492
DELISTED
Albireo Pharma Inc
ALBO
| $286K | ﹤0.01% |
+9,600
| New | +$281K |
|
|
BSQR
3493
DELISTED
BSQUARE Corporation
BSQR
| $286K | ﹤0.01% |
165,129
-117,473
| -42% | -$193K |
|
3494
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.18B
| $283K | ﹤0.01% |
4,400
-700
| -14% | -$45.1K |
|
|
GTH
3495
DELISTED
Genetron Holdings Limited ADS
GTH
| $283K | ﹤0.01% |
43,100
+22,571
| +110% | +$247K |
|
|
CYRN
3496
DELISTED
CYREN Ltd.
CYRN
| $282K | ﹤0.01% |
55,793
-12,903
| -19% | -$69.9K |
|
3497
Bionano Genomics
BNGO
$13.5M
| $281K | ﹤0.01% |
+181
| New | +$244K |
|
3498
Assembly Biosciences
ASMB
$614M
| $280K | ﹤0.01% |
11,325
-44,594
| -80% | -$957K |
|
3499
Torrid Holdings
CURV
$229M
| $279K | ﹤0.01% |
+45,962
| New | +$392K |
|
3500
ProShares UltraShort Energy
DUG
$18.3M
| $279K | ﹤0.01% |
3,100
+2,300
| +288% | +$273K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.